SNHG5 and osteosarcoma: SNHG5 was first revealed to be highly expressed as an oncogene in gastric cancer, and successive researchers subsequently reported that SNHG5 was differentially expressed in bladder cancer, lung cancer, liver cancer, cervical cancer, osteosarcoma, laryngeal cancer, oral cancer, and lymphoma.